Eli Lilly sues two pharmacies making copycat Zepbound, Mounjaro
Eli Lilly is suing Strive Pharmacy and Empower Pharmacy for compounding tirzepatide, the active ingredient in Zepbound and ...
The Pharma Letter3d
Lilly defends market with new action against GLP-1 compounders
With two new lawsuits, Eli Lilly (NYSE: LLY) has escalated its legal campaign against the makers of unauthorized versions of ...
Eli Lilly Vs. Hims & Hers In DTC Weight Loss Market? - There Is Only One Winner
Eli Lilly (LLY) leads with groundbreaking tirzepatide (Mounjaro/Zepbound), while Hims & Hers Health (HIMS) faces challenges.
Eli Lilly sues Strive and Empower as FDA lifts tirzepatide shortage status
Eli Lilly sues two compounders over tirzepatide after FDA lifts Zepbound, Mounjaro shortage status in key GLP-1 legal test.
NBC Los Angeles5d
Eli Lilly sues two pharmacies making copycat Zepbound, Mounjaro
Eli Lilly is suing two pharmacies for compounding Zepbound and Mounjaro ... and luring people away from Lilly's medicines. In lawsuits filed Tuesday in Delaware and New Jersey, Lilly alleges ...